Echocardiographic evaluation of acute cardiotoxicity in the treatment of Hodgkin disease according to the German Hodgkin's Lymphoma Study Group

Leukemia and Lymphoma

Volumn 43, Issue 12, 2002, Pages 2325-2329

  Krupicka J ^a   Markova J ^a   Pohlreich, D ^b   Kozak T ^a   Linkova H ^a   Diehl, V ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Cardiotoxicity; Echocardiography; German Hodgkin's lymphoma study group; Hodgkin's lymphoma

Indexed keywords

ANTHRACYCLINE; BLEOMYCIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE SULFATE; ANTINEOPLASTIC AGENT; ANTINEOPLASTIC ANTIBIOTIC;

ADULT; AGED; ARTICLE; CARDIOTOXICITY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; FOLLOW UP; GERMANY; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE SIZE; HEART LEFT VENTRICLE WALL MOTION; HODGKIN DISEASE; HUMAN; HYPOKINESIA; M MODE ECHOCARDIOGRAPHY; MAJOR CLINICAL STUDY; MALE; PATIENT MONITORING; PERICARDIAL EFFUSION; PRIORITY JOURNAL; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; ACUTE DISEASE; ADOLESCENT; CHEMICALLY INDUCED DISORDER; ELECTROCARDIOGRAPHY; HEART DISEASE; HEART STROKE VOLUME; HEART VENTRICLE REMODELING; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; TREATMENT OUTCOME;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; ELECTROCARDIOGRAPHY; FEMALE; HEART DISEASES; HODGKIN DISEASE; HUMANS; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 1842865276     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000040026     Document Type: Article

References (24)

1. Steinherz, L.J., Graham, T., Hurwitz, R., Sondheimer, H.M., Schwartz, R.G., Schaffer, E.M., Sandor, M., Benson, L. and Williams, R. (1992) "Guidelines for cardiac monitoring of children during and after anthracycline therapy: report of the cardiology committee of the childrens cancer study group", Pediatrics 89, 942-949.
2. Hancock, S.L. and Hoppe, R.T. (1996) "Long-term complications of treatment and causes of mortality after Hodgkin's disease", Seminars in Radiation Oncology 6, 225-242.
3. Bu'lock, F.A. (1995) "Anthracyclines and the heart", Primary Cardiology 21, 5-10.
4. Bristow, M.R., Thompson, P.D., Martin, R.P., Mason, J.W., Billingham, M.E. and Harrison, D.C. (1978) "Early anthracycline cardiotoxicity", American Journal of Medicine 65, 823-932.
5. Goebel, M. and Kaplan, E. (1992) "Anthracycline-induced cardiotoxicity", Review of Oncology 15, 198-204.
6. Rhoden, W., Hasleton, P. and Brooks, N. (1993) "Anthracyclines and the heart", British Heart Journal 70, 499-502.
7. Elbl, L., Vorlíček, J., Chaloupka, V., Hájek, R. and Vášová, I. (1997) "Anthracycline therapy induced myocardial damage", Klinická onkologie 10, 71-76.
8. Braunwald, E. and Grossman, W. (1992) "Clinical aspects of heart failure", In: Braunwald, E., Heart Disease, 4th Ed. (W. B. Saunders Company), pp 444-462.
9. Diehl, V. (1999) German Hodgkin's Lymphoma Study Group. Study protocols for primary treatment (HD10, HD11, HD12). Third Edition.
10. Diehl, V. (1993) German Hodgkin's Lymphoma Study Group. Study protocols for primary treatment (HD7, HD8, HD9). English short Version of the German Edition.
11. Schiller, N., Shah, P. and Crawford, M. (1989) "Recommendations for quantitation of the left ventricle by two-dimensional echocardiography", Journal of the American Society of Echocardiography 2, 358-367.
12. Roelandt, J. and Gibson, D.G. (1980) "Recommendations for standardization of measurement from M-mode echocardiograms", European Heart Journal 1, 375-378.
13. Krupička, J., Gregor, P., Buděšínský, T., Widimský, P. and Dvořák, J. (2002) "Echokardiografická kvantifikace změn kinetiky levé komory v průběhu hospitalizace u pacientů s prvním infarktem myokardu ošetřeným přímou angioplastikou", Vnitřní Lékařství, In press.
14. Diehl, V. and Josting, A. (2000) "Hodgkin's disease", Cancer Journal from Scientific American 6(Suppl. 2), 150-158.
15. Josting, A., Wolf, J. and Diehl, V. (2000) "Hodgkin disease: prognostic factors and treatment strategies", Current Opinion in Oncology 12, 403-411.
16. Hancock, S.L., Tucker, M.A. and Hoppe, R.T. (1993) "Factors affecting late mortality from heart disease after treatment of Hodgkin's disease", JAMA 270, 1949-1955.
17. Hancock, S.L., Donaldson, S.S. and Hoppe, R.T. (1993) "Cardiac disease following treatment of Hodgkin's disease in children and adolescents", Journal of Clinical Oncology 11, 1208-1215.
18. Armitage, J.O. (1998) "Long-term toxicity of the treatment of Hodgkin's disease", Annals of Oncology 9(Suppl. 5), 133-136.
19. Cosset, J.M. and Mauch, P.M. (1998) "The role of radiotherapy for early stage Hodgkin's disease: Limitations and perspectives", Annals of Oncology 9(Suppl. 5), 57-62.
20. Sieber, M., Ruffer, U., Josting, A. and Diehl, V. (1999) "Treatment of Hodgkin's disease: current strategies of the German Hodgkin's Lymphoma Study Group", Annals of Oncology 10(Suppl. 6), 23-29.
21. Sieber, M., Engert, A. and Diehl, V. (2000) "Treatment of Hodgkin's disease: results and current concepts of the German Hodgkin's Lymphoma Study Group", Annals of Oncology 11(Suppl. 1), 81-85.
22. Lipshultz, S.E., Sanders, S.P., Goorin, A.M., Krischer, J.P., Sallan, S.E. and Colan, S.D. (1994) "Monitoring for anthracycline cardiotoxicity", Pediatrics 93, 433-437.
23. Pohjola-Sintonen, S., Tötterman, K.J., Salmo, M. and Siltanen, P. (1987) "Late cardiac effects of mediastinal radiotherapy in patients with Hodgkin's disease", Cancer 60, 31-37.
24. Loyer, E., Fuller, L., Libshitz, H.I. and Palmer, J.L. (2000) "Radiographic appearance of the chest following therapy for Hodgkin disease", European Journal of Radiology 35, 136-148.